「ca」の検索結果
161件：36～40件目を表示
-
千寿製薬株式会社
hthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has developed and obtain...
http://www.senju.co.jp/english/ -
千寿製薬株式会社
hthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） 2025年09月04日 Senju has developed and obtained app...
http://www.senju.co.jp/chinese/ -
お知らせ | 千寿製薬株式会社
hthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） 2025年09月04日 Senju has developed and obtained app...
http://www.senju.co.jp/chinese/news/ -
General Announcement: Nov 26, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf -
产品开发方针 | 研究与开发 | 千寿制药株式会社
(META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-64. * 日本患者人数是根据#11～13的文献推算的 过敏性结膜炎 过敏性结膜炎是因为对花粉、尘螨和宠物毛发等过敏原产生反应、释放组胺而引起结膜炎症的疾病。...
http://www.senju.co.jp/chinese/rd/policy/